Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Loricrin cornified envelope precursor protein is the primary structural protein of the cornified envelope in the epidermis, comprising over 70% of its composition. It is critical for the formation and mechanical strength of the stratum corneum through protein cross-linking, enabling skin barrier function against environmental insults. Loricrin is a highly insoluble protein rich in glycine, serine, and cysteine residues, expressed exclusively in terminally differentiated keratinocytes in the upper layers of stratified epithelial tissues such as skin, oral and anal mucosa, esophagus, and vagina. Mutations lead to skin disorders like Vohwinkel syndrome and palmo-plantar keratoderma. Its altered expression is associated with dermatological diseases and has utility as a biomarker in the assessment of keratinization and potential malignant transformation in some mucosal lesions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Loricrin cornified envelope precursor protein (Loricrin).